CervoMed (CRVO)

• Market cap: $65.2M
• 1 day: -0.84%
• 5 days: 0.57%
• 1 month: -12.86%
• 3 months: -14.55%
• 6 months: -22.19%
• Year to date: 216.14%
• 1 year: -48.35%
• 5 years: -88.58%
• 10 years: -99.85%
• Sector: Healthcare
• Industry: Biotechnology

About: CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Employees: 15